Serum from Interferon-β-1b Treated MS Patients Induced In Vitro Stabilisation of the Blood-Brain Barrier

被引：0
|
作者：
Mueller, Marcus
Frese, Achim
Nassenstein, Isabelle
Hoppen, Maike
Marziniak, Martin
Ringelstein, E. Bernd
Kim, Kwang S.
Schaebitz, Wolf
Kraus, Joerg
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A417 / A417
页数：1
相关论文
共 50 条
  • [31] Serum antibodies from patients with neuropsychiatric systemic lupus erythematosus cause activation and damage to an in vitro blood-brain barrier model
    Mendonca, LLF
    Smith, R
    Hughes, GRV
    Dolman, DEM
    Dobbie, M
    Hurst, RD
    Abbott, NJ
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 525 : 38P - 38P
  • [32] Serum-derived factors in breast cancer patients change barrier properties of the human in vitro blood-brain barrier model
    Curtaz, Autoren C.
    Schmitt, C.
    Herbert, S-L
    Quenzer, A.
    Feldheim, J.
    Schlegel, N.
    Gosselet, F.
    Hagemann, C.
    Roewert, N.
    Meybohm, P.
    Woeckel, A.
    Burek, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E25 - E25
  • [33] Candesartan Improves Ischemia-Induced Impairment of the Blood-Brain Barrier In Vitro
    So, Gohei
    Nakagawa, Shinsuke
    Morofuji, Yoichi
    Hiu, Takeshi
    Hayashi, Kentaro
    Tanaka, Kunihiko
    Suyama, Kazuhiko
    Deli, Maria A.
    Nagata, Izumi
    Matsuo, Takayuki
    Niwa, Masami
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2015, 35 (04) : 563 - 572
  • [34] COMPUTATIONAL AND IN VITRO STUDIES OF BLAST-INDUCED BLOOD-BRAIN BARRIER DISRUPTION
    Del Razo, M. J.
    Morofuji, Y.
    Meabon, J. S.
    Huber, B. R.
    Peskind, E. R.
    Banks, W. A.
    Mourad, P. D.
    Leveque, R. J.
    Cook, D. G.
    SIAM JOURNAL ON SCIENTIFIC COMPUTING, 2016, 38 (03): : B347 - B374
  • [35] Interferon-beta stabilizes blood-brain barrier characteristics of cerebral endothelial cells in vitro
    Kraus, J
    Ling, AK
    Hamm, S
    Voigt, K
    Oschmann, P
    Engelhardt, B
    NEUROLOGY, 2004, 62 (07) : A384 - A384
  • [36] RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
    Iarlori, C
    Reale, M
    Lugaresi, A
    De Luca, G
    Bonanni, L
    Di Iorio, A
    Feliciani, C
    Conti, P
    Gambi, D
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 107 (01) : 100 - 107
  • [37] Effects of antibodies from patients with lupus psychosis in an in vitro blood-brain barrier model.
    Mendonca, LLF
    Smith, R
    Khamashta, MA
    Hughes, GRV
    Dolman, DEM
    Dobbie, M
    Hurst, RD
    Abbott, NJ
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S394 - S394
  • [38] Combined treatment of multiple sclerosis patients with cytostatics and interferon-β (1a,1b)
    Daskalovska, V
    Dimova, A
    Bojkovski, V
    Boskova-Petkovska, T
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S262 - S262
  • [39] Differential immunomodulatory effects of interferon-β1a/1b in patients with multiple sclerosis
    Papachroni, K.
    Fragoulis, N.
    Piperi, C.
    Patrikiou, A.
    Papadimitriou, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 142 - 142
  • [40] Effects of interferon-γ 1b on biomarker expression in patients with idiopathic pulmonary fibrosis
    Strieter, RM
    Starko, KM
    Enelow, RI
    Noth, I
    Valentine, VG
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (02) : 133 - 140
12345